Physicians' Awareness of ECG Abnormalities Linked to Acute Ischemic Chest Pain
- Conditions
- PhysiciansAwarenessAcute Ischemic Chest PainECG Abnormalities
- Registration Number
- NCT06836466
- Lead Sponsor
- Tanta University
- Brief Summary
This study aims to investigate physicians' awareness regarding patients presenting with potential acute ischemic chest pain. It focuses on various electrocardiogram (ECG) patterns requiring prompt catheter lab activation for reperfusion therapy alongside other ECG mimics that may lead to false catheter lab activations.
- Detailed Description
Chest pain is the second most common complaint in adult emergency department (ED) patients in the United States. Most visits result in a diagnosis of noncardiac chest pain and approximately half in nonspecific chest pain. Roughly 6% are ultimately diagnosed with a life-threatening condition, which is overwhelmingly (\>90%) acute coronary syndrome (ACS).
The term acute coronary syndrome (ACS) is applied to patients in whom there is a suspicion or confirmation of acute myocardial ischemia or infarction. ST-elevation myocardial infarction (STEMI), Non-ST-elevation MI (NSTEMI), and unstable angina are the three traditional types of ACS.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Age from 25 to 65 years.
- Both sexes.
- Physicians who treat patients with possible acute chest pain.
- Participants who failed to complete the survey questions.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Physicians' Awareness At time of online survey (Up to 2 months) Physicians' awareness is measured by a numerical score of 0 to 10, depending on the electrocardiogram (ECG) pattern survey. 0 means (least recognition of ECG pattern) and 10 (high recognition of ECG pattern)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Tanta University
🇪🇬Tanta, El-Gharbia, Egypt